Non categorizzato Regeneron to buy Sanofi’s stake in joint project for $900M Giugno 2, 2022 0 commenti Regeneron Pharmaceuticals Inc. announced on Wednesday that it will buy Sanofi S.A.’s stake in their joint Libtayo medicine program. Under the deal, Regeneron will first pay $900 million to Sanofi… About the author:
Get involved!
Comments